Overexpression of Crk in tumor cells or in experimental model systems leads to increases in tyrosine phosphorylation of p130Cas and the activation of an intracellular loop that further enhances the activity of Crk and induces increased motility and the aggressive potential of cancer cells. This evidence concerns the gene BCAR1 and neoplasm.